Logo image of LIFE.OL

LIFECARE ASA (LIFE.OL) Stock Fundamental Analysis

OSL:LIFE - NO0013355859 - Common Stock

9.54 NOK
-0.16 (-1.65%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall LIFE gets a fundamental rating of 3 out of 10. We evaluated LIFE against 58 industry peers in the Health Care Equipment & Supplies industry. While LIFE seems to be doing ok healthwise, there are quite some concerns on its profitability. LIFE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LIFE had negative earnings in the past year.
LIFE had a negative operating cash flow in the past year.
In the past 5 years LIFE always reported negative net income.
LIFE had a negative operating cash flow in each of the past 5 years.
LIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFLIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -63.73%, LIFE is not doing good in the industry: 87.93% of the companies in the same industry are doing better.
LIFE has a worse Return On Equity (-96.99%) than 82.76% of its industry peers.
Industry RankSector Rank
ROA -63.73%
ROE -96.99%
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
LIFE.OL Yearly ROA, ROE, ROICLIFE.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LIFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIFE.OL Yearly Profit, Operating, Gross MarginsLIFE.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

5

2. Health

2.1 Basic Checks

LIFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LIFE has more shares outstanding than it did 1 year ago.
LIFE has less shares outstanding than it did 5 years ago.
LIFE has a better debt/assets ratio than last year.
LIFE.OL Yearly Shares OutstandingLIFE.OL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LIFE.OL Yearly Total Debt VS Total AssetsLIFE.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

A Debt/Equity ratio of 0.11 indicates that LIFE is not too dependend on debt financing.
The Debt to Equity ratio of LIFE (0.11) is better than 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.01%
LIFE.OL Yearly LT Debt VS Equity VS FCFLIFE.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 2.54 indicates that LIFE has no problem at all paying its short term obligations.
LIFE has a better Current ratio (2.54) than 70.69% of its industry peers.
LIFE has a Quick Ratio of 2.54. This indicates that LIFE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.54, LIFE belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.54
LIFE.OL Yearly Current Assets VS Current LiabilitesLIFE.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

LIFE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.55%.
The Revenue for LIFE has decreased by -26.10% in the past year. This is quite bad
Measured over the past years, LIFE shows a very strong growth in Revenue. The Revenue has been growing by 36.13% on average per year.
EPS 1Y (TTM)-40.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1691.74%
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-80.89%

3.2 Future

LIFE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.53% yearly.
The Revenue is expected to grow by 45.55% on average over the next years. This is a very strong growth
EPS Next Y4.06%
EPS Next 2Y4.9%
EPS Next 3Y5.53%
EPS Next 5YN/A
Revenue Next Year-50%
Revenue Next 2Y8.01%
Revenue Next 3Y45.55%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIFE.OL Yearly Revenue VS EstimatesLIFE.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
LIFE.OL Yearly EPS VS EstimatesLIFE.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LIFE. In the last year negative earnings were reported.
Also next year LIFE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LIFE.OL Price Earnings VS Forward Price EarningsLIFE.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFE.OL Per share dataLIFE.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.9%
EPS Next 3Y5.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LIFE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFECARE ASA

OSL:LIFE (9/5/2025, 7:00:00 PM)

9.54

-0.16 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-27 2024-08-27/bmo
Earnings (Next)N/A N/A
Inst Owners4.42%
Inst Owner ChangeN/A
Ins Owners7.31%
Ins Owner ChangeN/A
Market Cap181.83M
AnalystsN/A
Price Target36.72 (284.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-64.35%
Min Revenue beat(2)-79.15%
Max Revenue beat(2)-49.54%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-23.35%
EPS NY rev (3m)-23.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-66.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.8
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 2.96
EV/EBITDA N/A
EPS(TTM)-4.53
EYN/A
EPS(NY)-4.58
Fwd EYN/A
FCF(TTM)-4.11
FCFYN/A
OCF(TTM)-3.44
OCFYN/A
SpS0.51
BVpS3.88
TBVpS3.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.73%
ROE -96.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 259.24%
Cap/Sales 131.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 2.54
Altman-Z N/A
F-Score2
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)168.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)55.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1691.74%
EPS Next Y4.06%
EPS Next 2Y4.9%
EPS Next 3Y5.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-80.89%
Revenue Next Year-50%
Revenue Next 2Y8.01%
Revenue Next 3Y45.55%
Revenue Next 5YN/A
EBIT growth 1Y-139.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.11%
EBIT Next 3Y7.32%
EBIT Next 5YN/A
FCF growth 1Y-103.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.56%
OCF growth 3YN/A
OCF growth 5YN/A